FIELD: medicine.
SUBSTANCE: invention concerns experimental medicine, namely to experimental rheumatology and can be used for pseudorheumatism modelling. For this purpose 4 mg of an ovalbumin into 1 ml of full Freund's adjuvant (FFA) in the knee joint area are entered subcutaneously. After ovalbumin introduction in FFA, intravenously a papain in a dose of mass of a body of 8-10 mg/kg is entered. Then for 12 days from the beginning of formation of model 5 mg of an ovalbumin is entered into a cavity of a knee joint, thus enter an ovalbumin in FFA unitary.
EFFECT: reduction of quantity of stages and terms of modelling of pseudorheumatism, formation of more expressed system inflammatory reactions in an organism that allows to spend approbation of complex ways of treatment with use not only locally - but also is system operating preparations.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR LOCAL THERAPY OF ANTIGEN-INDUCED ARTHRITIS | 2007 |
|
RU2347572C1 |
METHOD OF TREATMENT OF PATIENTS WITH AUTOIMMUNE ARTHRITIS | 2000 |
|
RU2169560C1 |
METHOD FOR TREATING RHEUMATOID ARTHRITIS | 2004 |
|
RU2269355C1 |
METHOD FOR MODELING RHEUMATOID ARTHRITIS CASES | 2005 |
|
RU2305328C1 |
METHOD OF INTRA-ARTICULAR TREATMENT OF ANTIGEN-INDUCED ARTHRITIS | 2007 |
|
RU2341268C1 |
AGENT FOR TREATING INFLAMMATORY DISEASES OF THE JOINTS | 2019 |
|
RU2707278C1 |
METHOD FOR INCREASING GENERAL NONSPECIFIC RESISTANCE OF MAMMAL BODY | 2009 |
|
RU2395960C1 |
RADIOPHARMACEUTICAL COMPOSITION FOR TREATMENT OF PAIN IN INFLAMMATORY DISEASES OF JOINTS | 2017 |
|
RU2662088C1 |
METHOD OF TREATING ARTHRITIS AND ARTHROSIS IN ANIMALS | 2011 |
|
RU2449802C1 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739747C1 |
Authors
Dates
2009-03-27—Published
2007-12-24—Filed